1. Home
  2. PRTC vs BYON Comparison

PRTC vs BYON Comparison

Compare PRTC & BYON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTC
  • BYON
  • Stock Information
  • Founded
  • PRTC 2015
  • BYON 1997
  • Country
  • PRTC United States
  • BYON United States
  • Employees
  • PRTC N/A
  • BYON N/A
  • Industry
  • PRTC Biotechnology: Pharmaceutical Preparations
  • BYON Catalog/Specialty Distribution
  • Sector
  • PRTC Health Care
  • BYON Consumer Discretionary
  • Exchange
  • PRTC Nasdaq
  • BYON Nasdaq
  • Market Cap
  • PRTC 432.3M
  • BYON 354.2M
  • IPO Year
  • PRTC N/A
  • BYON N/A
  • Fundamental
  • Price
  • PRTC $18.50
  • BYON $6.41
  • Analyst Decision
  • PRTC Buy
  • BYON Hold
  • Analyst Count
  • PRTC 1
  • BYON 8
  • Target Price
  • PRTC $45.00
  • BYON $10.67
  • AVG Volume (30 Days)
  • PRTC 3.2K
  • BYON 2.8M
  • Earning Date
  • PRTC 04-30-2025
  • BYON 07-28-2025
  • Dividend Yield
  • PRTC N/A
  • BYON N/A
  • EPS Growth
  • PRTC N/A
  • BYON N/A
  • EPS
  • PRTC 0.21
  • BYON N/A
  • Revenue
  • PRTC $4,828,000.00
  • BYON $1,244,431,000.00
  • Revenue This Year
  • PRTC $35.98
  • BYON N/A
  • Revenue Next Year
  • PRTC $115.38
  • BYON $12.55
  • P/E Ratio
  • PRTC $8.24
  • BYON N/A
  • Revenue Growth
  • PRTC 44.98
  • BYON N/A
  • 52 Week Low
  • PRTC $13.30
  • BYON $3.54
  • 52 Week High
  • PRTC $32.98
  • BYON $16.50
  • Technical
  • Relative Strength Index (RSI)
  • PRTC 58.17
  • BYON 62.31
  • Support Level
  • PRTC $17.80
  • BYON $5.50
  • Resistance Level
  • PRTC $19.17
  • BYON $7.10
  • Average True Range (ATR)
  • PRTC 0.48
  • BYON 0.49
  • MACD
  • PRTC 0.13
  • BYON 0.08
  • Stochastic Oscillator
  • PRTC 74.72
  • BYON 72.18

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

About BYON Beyond Inc.

Beyond Inc is an online retailer that provides products and services through websites. The company offers a broad number of products, including furniture, decor, area rugs, bedding and bath, home improvement, outdoor, and kitchen and dining items, BMMG (like books, magazines, CDs), electronics, and other items. The home and garden product line accounts for a material part of its total revenue. The company operates through a direct business that makes sales from the company's own inventory, and a partner business that sells merchandise from manufacturers, distributors, and other suppliers through the company's websites. The company generates the majority of its total revenue from partner business in terms of business format, and from the U.S. in terms of market.

Share on Social Networks: